UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

February 25, 2013
Date of Report (Date of Earliest Event Reported)

 

HOSPIRA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware
(State or Other Jurisdiction of Incorporation)

 

1-31946

 

20-0504497

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

275 N. Field Drive
Lake Forest, Illinois 60045
(Address Of Principal Executive Offices, including Zip Code)

 

Registrant’s Telephone Number, Including Area Code:  (224) 212-2000

 

Not Applicable
(Former Name or Former Address, If Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02                                           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On February 27, 2013, Mr. Brian Smith was appointed Senior Vice President, Chief Legal Officer of Hospira, Inc. (the “Company”), effective immediately.  Mr. Smith previously served as the Company’s Senior Vice President and General Counsel.

 

On February 27, 2013, Mr. Royce Bedward was appointed Corporate Vice President, General Counsel and Secretary, effective immediately.  Mr. Bedward previously served as the Company’s Deputy General Counsel and Secretary.

 

On February 25, 2013, Dr. Sumant Ramachandra provided notice to the Company that he will resign from the Company and his position as Senior Vice President, R&D, Medical and Regulatory Affairs and Chief Scientific Officer, effective March 8, 2013.

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned  hereunto duly authorized.

 

 

HOSPIRA, INC.

 

 

 

 

Dated: March 1, 2013

 

 

 

/s/ Royce Bedward

 

By:

Royce Bedward

 

Its:

Corporate Vice President, General Counsel and Secretary

 

2